Na Yeon Kim
Keine laufenden Positionen mehr
Vermögen: 40 594 $ am 30.04.2024
Karriereverlauf von Na Yeon Kim
Ehemalige bekannte Positionen von Na Yeon Kim
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.01.2021 | 18.09.2023 |
| Vorsitzender | 31.12.2019 | 01.01.2021 | |
| Independent Dir/Board Member | 31.12.2019 | 18.09.2023 | |
The Seed Investment Co. Ltd.
 The Seed Investment Co. Ltd. Investment ManagersFinance The Seed Investment Co Ltd (The Seed Investment) is a venture capital firm headquartered in Seoul, Korea. The firm is established in 2015 by The Seed Group Co Ltd. | Direktor/Vorstandsmitglied | 01.10.2015 | 01.03.2018 |
| MACROGEN, INC. | Direktor/Vorstandsmitglied | 01.01.2015 | 01.12.2017 |
Neurobo Therapeutics, Inc.
 Neurobo Therapeutics, Inc. BiotechnologyHealth Technology NeuroBo Therapeutics, Inc. engages in the development and research of treatment for neurodegenerative diseases. It focuses on novel therapies for diabetic neuropathic pain and central nervous system diseases. The company was founded by Roy Freeman and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Na Yeon Kim
| Yonsei University | Graduate Degree |
Statistik
International
| Südkorea | 4 |
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 4 |
| Chairman | 1 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Health Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MACROGEN, INC. | Health Services |
| NEUROBO PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
The Seed Investment Co. Ltd.
The Seed Investment Co. Ltd. Investment ManagersFinance The Seed Investment Co Ltd (The Seed Investment) is a venture capital firm headquartered in Seoul, Korea. The firm is established in 2015 by The Seed Group Co Ltd. | Finance |
Neurobo Therapeutics, Inc.
Neurobo Therapeutics, Inc. BiotechnologyHealth Technology NeuroBo Therapeutics, Inc. engages in the development and research of treatment for neurodegenerative diseases. It focuses on novel therapies for diabetic neuropathic pain and central nervous system diseases. The company was founded by Roy Freeman and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Na Yeon Kim
- Erfahrung
